Herr H W
Department of Surgery, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New York, New York.
Hematol Oncol Clin North Am. 1992 Feb;6(1):117-27.
Intravesical therapy is given as an adjunct to transurethral resection of superficial bladder tumors to eradicate existing disease, inhibit tumor recurrence, and prevent progression to muscle invasion or metastasis. Of the available agents, bacillus Calmette-Guerin (BCG) fulfills these goals and appears superior to chemotherapeutic drugs.
膀胱内灌注治疗作为浅表性膀胱肿瘤经尿道切除术的辅助治疗,用于根除现有疾病、抑制肿瘤复发,并预防进展为肌肉浸润或转移。在现有的治疗药物中,卡介苗(BCG)能够实现这些目标,且似乎优于化疗药物。